- Case Report
-
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
-
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
-
Clin Mol Hepatol. 2016;22(3):390-395. Published online August 30, 2016
-
-
-
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
-
Nae-Yun Heo, Young-Suk Lim, Han Chu Lee, Yung Sang Lee, Kang Mo Kim, Kwan Soo Byun, Kwang-Hyub Han, Kwan Sik Lee, Seung Woon Paik, Seung Kew Yoon, Dong Jin Suh
-
Clin Mol Hepatol. 2013;19(1):60-69. Published online March 25, 2013
-
-
-
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
-
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
-
Clin Mol Hepatol. 2012;18(3):272-278. Published online September 25, 2012
-
-
-
Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
-
Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol
-
Clin Mol Hepatol. 2011;17(3):183-188. Published online September 30, 2011
-
-
- 4
-
Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C
-
Yun Nah Lee, M.D., Soung Won Jeong, M.D., Jae Hee Lim, M.D., Yang Seon Ryu, M.D.,
Seong Ran Jeon, M.D., Sang Kyun Kim, M.D., Jae Young Jang, M.D.,
Young Seok Kim, M.D., Boo Sung Kim, M.D., Mi Oh Roh, M.D.
-
Clin Mol Hepatol. 2010;16(2):187-191. Published online June 25, 2010
-
-
- 3
-
Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b
-
Young-Joo Jin, M.D., Yoon Kyung Park, M.D., Gui Jun Yun, M.D. Han Chu Lee, M.D.,
Sook-Hyang Jeong, M.D. Gang Mo Kim, M.D., Young-Suk Lim, M.D., Young-Hwa Chung, M.D.,
Yung Sang Lee, M.D., Dong Jin Suh, M.D.
-
Clin Mol Hepatol. 2010;16(2):158-167. Published online June 25, 2010
-
-
View: 4176
Download: 22
-
Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection
-
Hong Ryeol Cheong, M.D., Hyun Young Woo, M.D., Jeong Heo, M.D.,
Ki Tae Yoon, M.D., Dong Uk Kim, M.D., Gwang Ha Kim, M.D.,
Dae Hwan Kang, M.D., Geun Am Song, M.D., Mong Cho, M.D.
-
Clin Mol Hepatol. 2010;16(1):38-48. Published online March 26, 2010
-
-
- 3
-
Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response
-
Soung Won Jeong, M.D., Jin Dong Kim, M.D. Hyun Young Woo, M.D.
Chan Ran You, M.D. Sung Won Lee, M.D. Myeong Jun Song, M.D. Jung Won Jang, M.D.
Si Hyun Bae, M.D. Jong Young Choi, M.D. Seung Kew Yoon, M.D.
-
Clin Mol Hepatol. 2009;15(3):338-349. Published online September 30, 2009
-
-
- 3
-
Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C
-
Chul Hyun Kim , Byung Do Park , Jin Woo Lee , Young Soo Kim , Seok Jeong , Don Haeng Lee , Hyung Gil Kim , Yong Woon Shin , Key Sook Kwon , Jung Il Lee
-
Clin Mol Hepatol. 2009;15(1):70-79. Published online March 31, 2009
-
-
|
Impact Factor8.9
